Reneo Pharmaceuticals, Inc. (RPHM)

NASDAQ: RPHM · IEX Real-Time Price · USD
+0.16 (2.95%)
Mar 29, 2023, 4:30 PM EDT - Market closed

Total Valuation

RPHM has a market cap or net worth of $136.88 million. The enterprise value is $37.17 million.

Market Cap 136.88M
Enterprise Value 37.17M

Important Dates

The next earnings date is Monday, May 8, 2023, before market open.

Estimated Earnings Date May 8, 2023
Ex-Dividend Date n/a

Share Statistics

RPHM has 24.53 million shares outstanding. The number of shares has increased by 35.01% in one year.

Shares Outstanding 24.53M
Shares Change (YoY) +35.01%
Shares Change (QoQ) +0.29%
Owned by Insiders (%) 3.18%
Owned by Institutions (%) 73.80%
Float 9.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 14.01
PB Ratio 1.37
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.93, with a Debt / Equity ratio of 0.01.

Current Ratio 14.93
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -44.10% and return on invested capital (ROIC) is -129.60%.

Return on Equity (ROE) -44.10%
Return on Assets (ROA) -40.90%
Return on Capital (ROIC) -129.60%
Revenue Per Employee n/a
Profits Per Employee -$1.62M
Employee Count 32
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +74.92% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change +74.92%
50-Day Moving Average 3.74
200-Day Moving Average 3.10
Average Volume (30 Days) 59,291

Short Selling Information

The latest short interest is 115,612, so 0.47% of the outstanding shares have been sold short.

Short Interest 115,612
Short Previous Month 95,339
Short % of Shares Out 0.47%
Short % of Float 1.25%
Short Ratio (days to cover) 1.44

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -53.85M
Pretax Income -51.96M
Net Income -51.96M
EBITDA -51.43M
EBIT -51.96M
Earnings Per Share (EPS) -$2.12
Full Income Statement

Balance Sheet

The company has $101.17 million in cash and $1.46 million in debt, giving a net cash position of $99.71 million or $4.06 per share.

Cash & Cash Equivalents 101.17M
Total Debt 1.46M
Net Cash 99.71M
Net Cash Per Share $4.06
Equity / Book Value 99.97M
Book Value Per Share 4.08
Working Capital 99.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$47.36 million and capital expenditures -$346,000, giving a free cash flow of -$47.71 million.

Operating Cash Flow -47.36M
Capital Expenditures -346,000
Free Cash Flow -47.71M
FCF Per Share -$1.95
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RPHM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -37.96%
FCF Yield -34.86%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -35.01%
Shareholder Yield -35.01%
Dividend Details

Analyst Forecast

The average price target for RPHM is $25.76, which is 361.65% higher than the current price. The consensus rating is "Buy".

Price Target $25.76
Price Target Difference 361.65%
Analyst Consensus Buy
Analyst Count 12
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a